Skip to main content
ACRS $3.48 -0.57%
ACRS logo
ACRS · Aclaris Therapeutics, Inc.
Track ACRS — free
$3.48 -0.02 (-0.57%) Q1 2024 earnings call transcript
Market Cap
$555.14M
Shares
158.61M
Volume · Nov 19 1.89M Avg daily vol (3M) 3.05M
All webcasts

Earnings call · FY2025 Q4

Aclaris Therapeutics, Inc. (ACRS) Q4 2025 Earnings Call

NoCallHeld Jan 6, 2026
Jan 6, 2026
Period
FY2025 Q4
Runtime
—
Sources
3 artifacts
Revenue · derived Q4 $1.29M -85.9% YoY
Gross margin · derived Q4 58.9% -33.4 pp YoY
Net income · derived Q4 -$19.80M
Open full screen 8-K 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 8-K call announcement, 10-K stay in one workspace.

Research coverage

3 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document